Compare Cassava Sciences Inc (FLNA) vs Upstart Holdings Inc (UPST) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Upstart Holdings (UPST) trades at $30.86, down 2.71% today, with a bearish technical signal from moving averages but oversold RSI conditions. The company reported a return to profitability in 2025 with $1.02B revenue and $53.60M net income, though recent Q1 2026 earnings missed expectations. Analyst sentiment is divided with a $42.00 consensus price target, while cash flow trends show improved but still negative operational cash generation.

UPST presents a high-risk, high-reward opportunity with strong AI lending growth potential but faces execution risks and margin pressure. The stock's current valuation at 77x P/E demands flawless execution of expansion into auto and home loans. Near-term performance hinges on Q2 2026 results due August 4, 2026, with investors watching for sustained profitability and funding stability.